Thalassemia pathology for neet pg 2026 visual aod

Reading File
search_medical_text

thalassemia pathology types alpha beta molecular defects hemolysis ineffective erythropoiesis

search_medical_image

thalassemia pathology diagram blood smear target cells ineffective erythropoiesis

GradeResponse
GradeResponse
Here is a comprehensive NEET PG 2026-focused breakdown of Thalassemia Pathology — visual and high-yield.

🩸 Thalassemia — Pathology (NEET PG 2026)


Pathophysiology Diagram — Beta-Thalassemia

Beta-thalassemia pathophysiology
Molecular cascade from α:β imbalance → ineffective erythropoiesis → iron overload + chronic anemia

Core Concept: Globin Chain Imbalance

Featureβ-Thalassemiaα-Thalassemia
Gene affectedβ-globin gene (chr 11)α-globin gene (chr 16)
Mutation typePredominantly point mutationsPredominantly deletions
Excess chainα-chains accumulateβ, γ, Γ-chains accumulate
Tetramers formedα₄ (Heinz bodies)β₄ (HbH), γ₄ (Hb Barts)
Oā‚‚ affinity of tetramersN/A (precipitate)Very HIGH — do not deliver Oā‚‚

β-Thalassemia: Step-by-Step Pathology

Step 1 — Molecular Defect

  • Mutations in β-globin gene → reduced (β⁺) or absent (β⁰) β-chain synthesis
  • Result: Excess unpaired α-chains → cannot form stable tetramers → precipitate inside erythroblasts

Step 2 — Hemichrome Formation & ROS

  • Precipitated α-chains → hemichromes → generate reactive oxygen species (ROS)
  • ROS → membrane lipid peroxidation → erythroblast membrane damage

Step 3 — Ineffective Erythropoiesis ⭐ (Most Important Mechanism)

  • Damaged erythroblasts are destroyed within the bone marrow before entering circulation
  • This is called intramedullary hemolysis / ineffective erythropoiesis
  • Predominant cause of anemia in β-thalassemia (Harrison's, p. 2927)
  • GDF11/GDF15 signaling → ↑ p-SMAD2/3 → ↓ GATA1 → ↑ apoptosis of erythroid precursors

Step 4 — Peripheral Hemolysis (Minor Component)

  • Cells that escape into circulation: ↓ deformability + phosphatidylserine exposure → extravascular + intravascular hemolysis

Consequences of Ineffective Erythropoiesis

Severe Anemia
     ↓
Marrow Expansion (erythroid hyperplasia)
     ↓
ā”Œā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”¬ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”
│ Skeletal Changes         │ Extramedullary            │
│ • "Hair on end"          │ Hematopoiesis             │
│   skull X-ray            │ • Hepatosplenomegaly       │
│ • Crew-cut appearance    │ • Paraspinal masses        │
│ • Frontal bossing        │                           │
│ • Rodent facies          │                           │
ā””ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”“ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”€ā”˜
     ↓
Iron Overload (↑ GI absorption + transfusions)
     ↓
Hemosiderosis → Liver cirrhosis, Dilated CMP,
                Diabetes, Hypogonadism

Iron Overload Mechanism (High-Yield)

MediatorRole
ERFE (Erythroferrone)↑ in ineffective erythropoiesis → ↓ Hepcidin
Hepcidin↓ → ↑ Ferroportin activity → ↑ GI iron absorption
TfR1 (Transferrin Receptor 1)↑ on erythroblasts → increased iron uptake
NEET PG Key Point: Ineffective erythropoiesis → ↑ ERFE → ↓ Hepcidin → Iron overload. This is independent of transfusions.

α-Thalassemia: Clinical Spectrum

GenotypeAlleles deletedClinical Picture
Silent carrier-α/αα (1 deleted)Normal, asymptomatic
α-Thal trait--/αα or -α/-α (2 deleted)Mild microcytic anemia
HbH disease--/-α (3 deleted)Moderately severe hemolytic anemia, HbH (β₄ tetramers)
Hb Barts (Hydrops fetalis)--/-- (4 deleted)Incompatible with life, γ₄ tetramers, severe tissue hypoxia
HbH inclusions stain with brilliant cresyl blue — "golf ball" cells

β-Thalassemia: Clinical Classification

TypeGenotypeHb levelTransfusion
Thalassemia Minor (Trait)β/β⁺ or β/β⁰9–11 g/dLNot required
Thalassemia Intermediaβ⁺/β⁺6–9 g/dLOccasional
Thalassemia Major (Cooley's anemia)β⁰/β⁰<6 g/dLRegular transfusions

Hemoglobin Electrophoresis Findings

ConditionHbAHbA2HbF
Normal97%2.5%<1%
β-Thal Minor↓↑ (>3.5%) ⭐↑ slightly
β-Thal MajorAbsent/↓↓↑↑↑ (up to 90%)
α-Thal trait↓Normal/↓Normal
HbH disease↓↓Normal + HbH
NEET PG Key: HbA2 >3.5% = hallmark of β-thalassemia trait. Used for carrier screening.

Peripheral Blood Smear Findings

  • Microcytic hypochromic RBCs
  • Target cells (codocytes) ⭐
  • Nucleated RBCs (nRBCs) — due to marrow stress
  • Basophilic stippling
  • Poikilocytosis (tear drop cells, elliptocytes)
  • Elevated reticulocyte count (though paradoxically low given the degree of anemia)

Complications Summary (Thalassemia Major)

SystemComplication
CardiacDilated cardiomyopathy (iron) — #1 cause of death
LiverCirrhosis, hepatocellular carcinoma
EndocrineDiabetes, hypogonadism, hypothyroidism, short stature
BoneOsteoporosis, pathological fractures
ImmuneAsplenia (post-splenectomy) → encapsulated organisms

Treatment (NEET PG Essentials)

TreatmentDetails
Regular blood transfusionTarget Hb >10 g/dL; monthly
Iron chelationDesferrioxamine (IV/SC), Deferasirox (oral), Deferiprone (oral)
SplenectomyReduces transfusion requirement; risk of sepsis
Hydroxyurea↑ HbF production (β-thal intermedia)
LuspaterceptAnti-GDF11 → ↓ ineffective erythropoiesis (newer drug)
HSCT (Bone Marrow Transplant)Only curative option
Gene therapyBetibeglogene (Zynteglo) — approved for β-thalassemia

High-Yield One-Liners for NEET PG 2026

  1. Predominant mechanism of anemia in β-thalassemia = Ineffective erythropoiesis (not hemolysis)
  2. α-thalassemia = gene deletions; β-thalassemia = gene point mutations
  3. HbA2 >3.5% = β-thalassemia trait (carrier screening test)
  4. Hb Barts (γ₄) = 4-gene deletion α-thal = hydrops fetalis
  5. HbH (β₄) = 3-gene deletion = golf ball cells with BCB stain
  6. Ferritin ↑↑ in thalassemia major despite iron deficiency picture on smear (due to overload)
  7. Cardiac hemosiderosis = #1 cause of death in thalassemia major
  8. Curative treatment = Allogeneic HSCT
  9. Rodent facies + hair-on-end skull X-ray = thalassemia major (marrow expansion)
  10. Target cells on smear + microcytic anemia with normal/high serum iron = think thalassemia (not IDA)

Sources: Harrison's Principles of Internal Medicine, 21st Edition (p. 2927); PMC Clinical VQA — β-thalassemia pathophysiology diagram
This is a shared conversation. Sign in to Orris to start your own chat.